IP Library Granted Patent US 10,143,857
Granted Patent B2
US 10,143,857 · App. 15/684,693 · Granted Dec 4, 2018

Systems and methods for use in emission guided radiation therapy

Inventors: Samuel Mazin (Menlo Park, CA); Akshay Nanduri (San Francisco, CA)
Assignee: RefleXion Medical, Inc.
A61N5/1065A61B5/055A61B6/032A61B6/037A61B6/12A61B6/469A61B6/54A61N5/1039A61N5/1042A61N5/1048A61N5/1067A61N5/1081G01T1/2907G01T1/2985A61B2090/374A61B2090/3762A61N5/1001A61N5/1045A61N2005/1074A61N2005/1087
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,143,857
App. No.
15/684,693
Granted
Dec 4, 2018
Kind
B2
Abstract

Described herein are systems and methods for positioning a radiation source with respect to one or more regions of interest in a coordinate system. Such systems and methods may be used in emission guided radiation therapy (EGRT) for the localized delivery of radiation to one or more patient tumor regions. These systems comprise a gantry movable about a patient area, where a plurality of positron emission detectors, a radiation source are arranged movably on the gantry, and a controller. The controller is configured to identify a coincident positron annihilation emission path and to position the radiation source to apply a radiation beam along the identified emission path. The systems and methods described herein can be used alone or in conjunction with surgery, chemotherapy, and/or brachytherapy for the treatment of tumors.

Claims (30)

1. A system for positioning a radiation source comprising:

a gantry;

a radiation source mounted on the gantry;

positron emission detectors mounted on the gantry, wherein the positron emission detectors are configured to detect a positron annihilation emission path that intersects a region of interest within a coordinate system; and

a controller in communication with the radiation source and the positron emission detectors, the controller configured to

determine, using an image of the region of interest acquired by a selected imaging modality, whether the detected emission path intersects a variable density region,

if the detected emission path intersects a variable density region, calculate an attenuation factor based on the density of the intersected variable density region, and

position the radiation source with respect to the emission path, wherein the radiation source is configured to generate radiation that is modulated by the attenuation factor.

2. The system of claim 1 , wherein the radiation source is configured to generate radiation that is adjusted to compensate for attenuation of the radiation along the detected emission path.

3. The system of claim 1 , wherein the selected imaging modality is selected from the group consisting of CT imaging, MRI imaging, X-ray imaging and PET imaging.

4. The system of claim 3 , wherein the radiation source is configured to generate radiation that is proportional to attenuation of the detected emission path.

5. The system of claim 3 , wherein the radiation source is configured to generate radiation that is inversely proportional to attenuation of the detected emission path.

6. The system of claim 1 , wherein the radiation source is configured to generate radiation having an intensity that is modulated proportionally to the attenuation factor.

7. The system of claim 1 , wherein the radiation source is configured to generate radiation with a time duration that is modulated proportionally to the attenuation factor.

8. The system of claim 1 , wherein the radiation source is configured to generate radiation with an intensity that is modulated inversely proportionally to the attenuation factor.

9. The system of claim 1 , wherein the radiation source is configured to generate radiation with a time duration that is modulated inversely proportionally to the attenuation factor.

10. The system of claim 1 , wherein the variable density region has a higher density than the region of interest.

11. The system of claim 1 , wherein calculating the attenuation factor comprises:

calculating a density projection of the region of interest along the emission path;

converting the density projection to emission path photon energies; and

deriving the attenuation factor based on emission path photon energies.

12. The system of claim 1 , wherein positioning the radiation source comprises aligning the radiation source along the emission path.

13. The system of claim 1 , wherein the detected positron annihilation emission path is defined by a pair of photons emitted by a positron annihilation event, and the controller is further configured to

calculate a time difference between the detection of each of the photons in the pair of photons,

calculate a location of the positron annihilation event based on the calculated time difference, wherein the location calculation has an estimation error,

determine whether the location of the positron annihilation event is within the estimation error from a boundary of the region of interest, and

send an instruction to the radiation source to generate radiation to the region of interest that is modulated by the attenuation factor if the location of the positron annihilation event is within the estimation error from the boundary of the region of interest.

14. The system of claim 1 , wherein the image of the region of interest is acquired during a radiotherapy treatment session.

15. The system of claim 1 , wherein the controller is configured to dynamically calculate the attenuation factor during a radiotherapy treatment session using positron emission detector data.

16. The system of claim 1 , further comprising an X-ray detector, wherein the controller is configured to dynamically calculate the attenuation factor during a radiotherapy treatment session using X-ray detector data.

Assignments (4)
RELEASE OF SECURITY INTEREST Recorded Jul 11, 2022
From: OXFORD FINANCE LLC
To: REFLEXION MEDICAL, INC.
Reel/Frame 060469/0862 →
SECURITY INTEREST Recorded Jul 11, 2022
From: REFLEXION MEDICAL, INC.
To: OXFORD FINANCE LLC
Reel/Frame 060619/0066 →
SECURITY INTEREST Recorded Apr 26, 2019
From: REFLEXION MEDICAL, INC.
To: OXFORD FINANCE LLC
Reel/Frame 049009/0372 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 23, 2017
From: MAZIN, SAMUEL; NANDURI, AKSHAY
To: REFLEXION MEDICAL, INC.
Reel/Frame 043656/0875 →
Continuity (5)
Division 15499671 · Apr 27, 2017
Division 15047552 · Feb 18, 2016
Division 14007312
Provisional Application 61470432 · Mar 31, 2011
Related Publication 20180001109A1 · Jan 4, 2018
Cited By (4)
US 12,251,579 US 12,502,554 US 12,582,845 US 12,700,100